Karen Sterling

Stock Analyst at WBB Securities

(2.22)
# 0
Out of 0 analysts
1
Total ratings
100%
Success rate
12.7%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Karen Sterling

enGene Therapeutics
Apr 13, 2026
Initiates: Buy
Price Target: $22
Current: $6.96
Upside: +208.91%